PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic

By Papa Anne-Laure   Sidiqui Almas   Balasubramanian Sri   Sarangi Sasmit   Luchette Matthew   Sengupta Shiladitya   Harfouche Rania  

Cellular Oncology, Vol. 36, Iss. 6, 2013-12 ,pp. : 449-457

Springer Publishing Company

Access to resources Recommend Favorite

FreeBRing flavonoids as potential lead compounds for colon cancer therapy

By              

Molecular and Clinical Oncology, Vol. 2, Iss. 4, 2014-01 ,pp. : 581-585

Spandidos Publications

Access to resources Recommend Favorite

NK-CTLs, a novel HLA-E-restricted T-cell subset

By Moretta L.   Romagnani C.   Pietra G.   Moretta A.   Mingari M.C.  

Trends in Immunology, Vol. 24, Iss. 3, 2003-03 ,pp. : 136-143

Elsevier

Access to resources Recommend Favorite

Targeted Correction of the Point Mutations of β-Thalassemia and Targeted Mutagenesis of the Nucleotide Associated with HPFH by RNA/DNA Oligonucleotides: Potential for β-Thalassemia Gene Therapy

By Li Z-H.   Liu D-P.   Yin W-X.   Guo Z-C.   Liang C-C.  

Blood Cells, Molecules, and Diseases, Vol. 27, Iss. 2, 2001-02 ,pp. : 530-538

Academic Press

Access to resources Recommend Favorite

What Makes Y Family Pols Potential Candidates for Molecular Targeted Therapies and Novel Biotechnological Applications

By  

Current Molecular Medicine, Vol. 14, Iss. 1, 2014-01 ,pp. : 96-114

Bentham Science Publishers

Access to resources Recommend Favorite